Molecular Epidemiology and Mechanisms of Carbapenem Resistance in Pseudomonas aeruginosa

被引:247
作者
Rodriguez-Martinez, Jose-Manuel
Poirel, Laurent
Nordmann, Patrice [1 ]
机构
[1] Univ Paris 11, Hop Bicetre, Serv Bacteriol Virol, F-94275 Le Kremlin Bicetre, France
关键词
EXTENDED-SPECTRUM CEPHALOSPORINASES; METALLO-BETA-LACTAMASE; EFFLUX SYSTEM; CLINICAL STRAINS; PORIN OPRD; EXPRESSION; GENE; INVOLVEMENT; INTERPLAY; PUMPS;
D O I
10.1128/AAC.00574-09
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The contributions of different mechanisms of resistance to carbapenems among a collection of imipenemand meropenem-nonsusceptible Pseudomonas aeruginosa isolates were investigated. This screening included the recently reported extended-spectrum cephalosporinases (ESACs) weakly hydrolyzing carbapenems. Eighty-seven percent of the studied isolates were resistant to imipenem. Genes encoding metallo-beta-lactamases or carbapenem-hydrolyzing oxacillinases were not identified. The main mechanism associated with imipenem resistance was the loss of outer membrane protein OprD. Identification of overexpressed ESACs and loss of OprD were observed for 65% of the isolates, all being fully resistant to imipenem. Resistance to meropenem was observed in 78% of the isolates, with all but one also being resistant to imipenem. Overexpression of the MexAB-OprM, MexXY-OprM, or MexCD-OprJ efflux systems was observed in 60% of the isolates, suggesting the contribution of efflux mechanisms in resistance to meropenem. The loss of porin OprD and the overproduction of ESACs were observed in 100% and 92% of the meropenem-resistant isolates, respectively. P. aeruginosa can very often accumulate different resistance mechanisms, including ESAC production, leading to carbapenem resistance.
引用
收藏
页码:4783 / 4788
页数:6
相关论文
共 24 条
[1]   Involvement of an active efflux system in the natural resistance of Pseudomonas aeruginosa to aminoglycosides [J].
Aires, JR ;
Köhler, T ;
Nikaido, H ;
Plésiat, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (11) :2624-2628
[2]   Molecular and biochemical heterogeneity of class B carbapenem-hydrolyzing β-lactamases in Chryseobacterium meningosepticum [J].
Bellais, S ;
Aubert, D ;
Naas, T ;
Nordmann, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (07) :1878-1886
[3]  
*CLSI, 2008, M100S18 C6S2
[4]  
El Amin N, 2005, APMIS, V113, P187, DOI 10.1111/j.1600-0463.2005.apm1130306.x
[5]   C-terminal region of Pseudomonas aeruginosa outer membrane porin OprD modulates susceptibility to meropenem [J].
Epp, SF ;
Köhler, T ;
Plesiat, P ;
Michea-Hamzehpour, M ;
Frey, J ;
Pechère, JC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (06) :1780-1787
[6]   Establishment of a real-time PCR-based approach for accurate quantification of bacterial RNA targets in water, using Salmonella as a model organism [J].
Fey, A ;
Eichler, S ;
Flavier, S ;
Christen, R ;
Höfle, MG ;
Guzmán, CA .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2004, 70 (06) :3618-3623
[7]   CTX-M Expression and Selection of Ertapenem Resistance in Klebsiella pneumoniae and Escherichia coli [J].
Girlich, Delphine ;
Poirel, Laurent ;
Nordmann, Patrice .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (02) :832-834
[8]   Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals [J].
Gutierrez, O. ;
Juan, C. ;
Cercenado, E. ;
Navarro, F. ;
Bouza, E. ;
Coll, P. ;
Perez, J. L. ;
Oliver, A. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (12) :4329-4335
[9]   Resistance mechanisms of multiresistant pseudomonas aeruginosa strains from Germany and correlation with Hypermutationdel [J].
Henrichfreise, B. ;
Wiegand, I. ;
Pfister, W. ;
Wiedemann, B. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (11) :4062-4070
[10]   Involvement of the MexXY-OprM efflux system in emergence of cefepime resistance in clinical strains of Pseudomonas aeruginosa [J].
Hocquet, D ;
Nordmann, P ;
El Garch, F ;
Cabanne, L ;
Plésiat, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (04) :1347-1351